WALNUT, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today announced the full repayment of its outstanding debt obligations to YA II PN, Ltd. (“YA II”) pursuant to a certain Standby Equity Purchase Agreement dated November 25, 2024 (the “SEPA”), by and between the Company and YA ...

Occidental Petroleum (OXY) is losing ground on Thursday after famed investor Warren Buffett’s conglomerate Berkshire Hathaway (BRK.A) (BRK.B) confirmed plans of buying its petrochemical unit – OxyChem. Berkshire has agreed to pay $9.7 billion in cash for OxyChem, which makes it the giant’s largest deal since 2022. The transaction adds to Berkshire’s existing 28.2% stake in OXY shares. More News from Barchart Despite today’s decline, Occidental Petroleum stock remains up some 25% versus its year-to-dat ...

Transaction Strengthens Balance Sheet and Improves Position for Accretive M&A NEW YORK CITY, NY / ACCESS Newswire / October 1, 2025 / Capstone Holding Corp.("Capstone" or the "Company") (NASDAQ:CAPS), a national building products distribution platform, today announced the exchange of $1.9 million in debt by a related party for a newly issued series of non-convertible preferred equity. This strategic deleveraging retires 100% of the targeted debt and lowers 2026 interest expense by more than $170k. ...

deleveraging. In a deleveraging, people cut spending, incomes fall, credit disappears, asset prices drop, banks get squeezed, the stock market crashes, social tensions rise, and the whole thing starts to feed on itself the other way. As incomes fall and debt repayments rise, borrowers get squeezed.no longer creditw worthy, credit dries up and borrowers can no longer borrow enough money to make their debt repayments. Scrambling to fill this hole, borrowers are forced to sell assets. The rush to sell assets f ...

MONACO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced today that it has entered into agreements to sell two vessels and provided an update on its outstanding debt. Vessel Sales The Company has recently entered into agreements to sell two 2019 built scrubber-fitted LR2 product tankers, STI Lobelia and STI Lavender, for $61.2 million per vessel. The sales are expected to close within the fourth quarter of 2025. Emanuele Lauro, Chairman and ...

Market Overview - Bitcoin (BTC) price stabilized around $109,000 following US inflation data that met expectations, with sellers maintaining pressure as Wall Street opened [1] - The core personal consumption expenditures (PCE) index rose by 2.9% annually in August, while the headline PCE increased by 2.7%, both aligning with economist forecasts [1][2] - The market reaction was muted due to the lack of surprises in the inflation data, although the readings above the Fed's target suggest potential for an October rate cut [2] Trading Dynamics - Order-book data indicated bid support around $108,200 on Binance, with liquidation levels just above $110,000 [2] - A significant deleveraging event occurred, with reports of long liquidations when BTC dipped below $111,000, indicating ongoing market adjustments [2][3] - Analysts identified $107,000–$108,000 as the next support level and $112,000-$117,000 as resistance, following the largest deleveraging event of 2025 [3] Company-Specific Concerns - A crypto analyst warned that Bitcoin may be entering its largest bear market, with MicroStrategy's holdings being a focal point of concern [4] - Current trading levels for Bitcoin are in the mid-$80,000 range, which is below its estimated average cost basis, raising fears of further price declines into 2026 [5] - If Bitcoin prices fall to $65,000 or $45,000, MicroStrategy may be compelled to sell part of its substantial 639,835 BTC holdings, which could significantly impact its balance sheet [5][6] - MicroStrategy, led by Michael Saylor, has built the largest corporate Bitcoin treasury, but its aggressive leverage strategy has drawn both praise and scrutiny [6]

Summary of Conference Call Company and Industry - The conference call pertains to LANXESS, a significant player in the polymer industry, particularly in polyamide production, and its strategic decision regarding its joint venture with Invia [2][3]. Core Points and Arguments 1. **Strategic Decision on Invia Shares**: LANXESS announced its decision to exercise the right to sell its shares in Invia, with the first closing yielding proceeds of €1.3 billion, exceeding initial market evaluations of €600 million to €700 million [3][4]. 2. **Reduction of Automotive Exposure**: The company has successfully reduced its automotive exposure to approximately 10% of total sales, down from a significant portion previously [4]. 3. **Deleveraging Efforts**: LANXESS has reduced its net debt from €3.8 billion to €2.1 billion, emphasizing a strong commitment to deleverage its balance sheet further [4]. 4. **Future Valuation and EBITDA**: The company locked in a base value of €1.2 billion for the joint venture, with the potential for future upside based on performance metrics, particularly EBITDA [6][10]. 5. **Put Option Timeline**: The first opportunity to sell 41% of the stake in Invia to partner Edmond is in April 2026, contingent on Edmond's financing capabilities [13][34]. 6. **Market Expectations for EBITDA**: Standard & Poor's projects EBITDA for Invia to be between €310 million and €420 million for 2024 and 2025, respectively, with LANXESS's own calculations indicating a potential 20% improvement in performance [20][21]. 7. **Shareholder Loan Consideration**: The proceeds from the sale will also consider a shareholder loan provided to Invia, which will be factored into the overall financial equation [10]. Important but Overlooked Content 1. **Joint Exit Strategy**: LANXESS has indicated that any future exit from Invia will likely be a joint exit with Edmond, emphasizing a collaborative approach to divestment [15][30]. 2. **Legal and Financial Safeguards**: The company has established contractual rights and obligations to ensure that Edmond demonstrates financial capability to execute the transaction, reflecting a well-thought-out negotiation process [24][26]. 3. **Market Environment Considerations**: The decision to exercise the put option was influenced by current market dynamics and the need to evaluate balance sheets, indicating a strategic approach to timing [39]. This summary encapsulates the key discussions and strategic insights shared during the conference call, highlighting LANXESS's focus on financial prudence and market positioning within the polymer industry.

Core Viewpoint - BofA Securities maintains a Buy rating on Carnival Corporation with a price target of $38, anticipating results in line with consensus for the third-quarter earnings report on September 29 [1] Group 1: Industry Insights - Recent industry commentary presents mixed signals, with Royal Caribbean showing a softer yield outlook while Norwegian Cruise Line aligns more closely with forecasts [1] - Both operators indicate strength in close-in bookings and onboard spending [1] Group 2: Company Performance Indicators - BofA's internal card data reveals that monthly cruise spending growth accelerated to 11.9% year-on-year in August, up from 9% in July, which is expected to support Carnival's results [2] - The bullish outlook on Carnival is attributed to strong fundamentals, the launch of Celebration Key in July providing a yield tailwind, ongoing deleveraging with limited capital expenditures, and an attractive valuation at 8.5x estimated 2026 EBITDAR compared to a historical average of 10x [2]

Core Thesis - Bausch Health Companies Inc. (BHC) is viewed positively despite significant share price decline, with a current trading price of $7.25 and trailing and forward P/E ratios of 27.88 and 1.76 respectively [1][2] Company Overview - BHC is a diversified healthcare company involved in pharmaceuticals and medical devices, with operations in eye care, gastroenterology, neurology, dermatology, and aesthetics [2] - The company has experienced an 80% decline in share price since July 2021, attributed to higher interest rates, policy uncertainty, and post-COVID overcapacity [2] Financial Performance - BHC generates stable cash flows with a five-year revenue CAGR of 3.5%, LTM EBITDA margins of 31.5%, and a free cash flow yield of 35.8% [3] - The company has a significant leverage issue, with $20 billion in net debt against $3.1 billion in EBITDA, leading to steep discounts of 66.5% on TEV/EBITDA and 31.5% on TEV/sales compared to peers [3] Recent Developments - The 2022 spin-off of Bausch + Lomb (BLCO) resulted in a $630 million debt reduction, and BHC retains an 87.5% stake in BLCO valued at $4.8 billion, nearly double its market cap [3] - A $6 billion maturity wall is due in 2028, and the 2029 patent expiry of the $1.9 billion IBS drug Xifaxan is raising solvency concerns [4] Market Sentiment and Risks - A recent acquisition by Paulson Capital of a 34 million-share block at a 19.8% premium indicates potential asset monetization, which could help in deleveraging [4] - Scenario modeling suggests a 39% probability of bankruptcy versus a 20% chance of significant gains, indicating a highly asymmetric risk/reward profile [5]

Core Insights - Carnival Corporation & plc (CCL) achieved record customer deposits in Q2 2025, increasing by over $250 million year-over-year, indicating strong underlying demand and effective cash inflow management ahead of sailings [1][8] - The company reported a 6.5% year-over-year growth in net yields, surpassing guidance by 200 basis points, driven by extended booking windows and a focus on same-ship revenue growth [2][8] - CCL improved its net debt-to-EBITDA ratio to 3.7x from 4.1x, supported by record operating results and refinancing, enhancing its balance sheet and liquidity [3][8] Booking and Revenue Strategy - The increase in deposits reflects CCL's successful strategy of extending the booking window, allowing for better yield management and pricing optimization as sailings approach [2] - Upcoming product catalysts, including a new private destination in the Caribbean, are expected to further boost deposits and enhance revenue visibility [4] Competitive Landscape - Royal Caribbean Cruises Ltd. (RCL) reported strong forward bookings for 2025, with both volume and pricing exceeding last year's levels, contributing to higher advance cash collections [5] - Norwegian Cruise Line Holdings Ltd. (NCLH) also noted record Advanced Ticket Sales (ATS) of approximately $4 billion, indicating robust demand and serving as a strategic funding source for debt reduction [6] Financial Performance and Valuation - CCL's stock has increased by 32.1% over the past three months, outperforming the industry growth of 13.4% [7] - The forward price-to-earnings ratio for CCL stands at 14.04X, significantly lower than the industry average of 18.63X, suggesting potential undervaluation [10] - The Zacks Consensus Estimate projects a year-over-year earnings increase of 41.6% for fiscal 2025 and 14.1% for fiscal 2026, with EPS estimates having risen in the past 60 days [11]